Authors | Age (yrs) | Presenting symptoms | Histological features associated and FIGO stage | HPV | ER/PGR | Treatment | Outcome |
---|---|---|---|---|---|---|---|
Moll et al (1990) | 50 | Post-coital vaginal bleeding, menometrorrhagia | III (metastases of ovary and lymph nodes) | Not done | Not done | Surgery and whole pelvic irradiation | DOD 10 mo |
Mayorga et al (1997) | 68 74 | Post-coital bleeding Post-menopausal bleeding | Ib Ib | Not done Not done | Not done Not done | Preoperative chemotherapy and surgery Surgery | NED 35 mo NED 25 mo |
Haswani et al (1998) | 33 38 | Asymptomatic AGC-NOS on a routine vaginal smear) Post-coital vaginal bleeding In both cases previous cervical condylomas | Adenosquamous ca, III, N1 AIS/HSIL Ib N1 | HPV type 18 by PCR Not done | -/ --/- | Palliative radio and chemotherapy Surgery and radiotherapy | DOD 10 mo NED 18 mo |
Cardosi et al. (1999) | 53 | Perimenopausal bleeding | neuroendocrine differentiation Ib | Not done | +/+ | Surgery, radiotherapy Chemotherapy | NED 6 mo |
Moritani et al (2004) | 29 | Persistent abnormal genital bleeding | glassy cell component III b N1 | - by immunohistochemistry | -/- | Chemotherapy | NED 6 mo |
Insabato et al (2007) | 46 | Vaginal bleeding in cervical polypoid lesion | Ib | Not done | Not Done | Surgery radiotherapy Chemotherapy | NED 3 yrs |
Suárez-Peñaranda (2007) | 80 | Vaginal discharge | neuroendocrine differentiation IIIb | Not done | Not Done | Radiotherapy/Chemotherapy | DOD 18 mo |
McCluggage WG et al (2008) | NR | Two cases NR | Foci of signet-ring cell in the usual type of cervical adenocarcinoma Diffuse positivity to P16 | Not done | Not Done | NR | NR |
Versas E et al (2009) | 36 43 | Thromboembolic events (Trousseau Syndrome)Metastases of lung and lymph nodes | Â | + HPV by in situ hybridization | -/- -/- | Chemotherapy Chemotherapy | DOD 7 wks DOD 2 mo |
Balci et al (2010) | 53 | Post-menopausal bleeding | (0% of neoplasms with SRC II b3x 5 × 2 parametrio N1 | HPV type 18 | -/- | Surgery | NR |